Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Luque, Ana ^a   Farwati, Abduljalil ^a   Crovetto, Francesca ^b,c   Crispi, Fatima ^b   Figueras, Francesc ^b   Gratacós, Eduard ^b   Aran, Josep M ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; PRE-ECLAMPSIA; PREGNANCY;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MICRORNAS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 84907926494     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04882     Document Type: Article

References (59)

1. Sibai, B., Dekker, G. & Kupferminc, M. Pre-eclampsia. Lancet 365, 785-799 (2005
2. Bujold, E. et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-Analysis. Obstet Gynecol 116, 402-414 (2010
3. Roberts, J. M.&Cooper, D. W. Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53-56 (2001
4. Zhang, C. MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33, 139-147 (2008
5. Urbich, C., Kuehbacher, A. & Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79, 581-588 (2008
6. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004
7. Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C. Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22, 125-132 (2012
8. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006 (2008
9. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513-10518 (2008
10. Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285, 17442-17452 (2010
11. Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108, 5003-5008 (2011
12. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R.D.&Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by highdensity lipoproteins. Nat Cell Biol 13, 423-433 (2011
13. Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C. Y. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 3, 28-37 (2012
14. De Guire, V. et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: Promises and challenges. Clin Biochem 46, 846-860 (2013
15. Pineles, B. L. et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196, 261.e1-6 (2007
16. Hu, Y. et al. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47, 923-929 (2009
17. Zhu, X. M., Han, T., Sargent, I. L., Yin, G. W. & Yao, Y. Q. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200, 661.e1-7 (2009
18. Enquobahrie, D. A. et al. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204, 178 e12-21 (2011
19. Wang, W. et al. Preeclampsia up-regulates angiogenesis-Associated microRNA (i.e., miR-17,-20a, and-20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 97, E1051-E1059 (2012
20. Gunel, T. et al. Serum microRNA expression in pregnancies with preeclampsia. Genet Mol Res 10, 4034-4040 (2011
21. Anton, L. et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol 183, 1437-1445 (2013
22. Hromadnikova, I. et al. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm 2013, 186041 (2013
23. Wu, L. et al. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction 143, 389-397 (2012
24. Stubert, J. et al.miRNAexpression profiles determined in maternal sera of patients with HELLP syndrome. Hypertens Pregnancy doi:10.3109/10641955.2013.858743 (2013
25. Yang,Q. et al.Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta 412, 2167-2173 (2011
26. Li, H., Ge, Q., Guo, L. & Lu, Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int 2013, 970265 (2013
27. Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, e179 (2005
28. Roberge, S. et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-Analysis. Fetal Diagn Ther 31, 141-146 (2012
29. Crispi, F. et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195, 201-207 (2006
30. Valensise, H., Vasapollo, B., Gagliardi, G. & Novelli, G. P. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52, 873-880 (2008
31. van der Merwe, J. L.,Hall, D. R.,Wright, C., Schubert, P.&Grove, D. Are early and late preeclampsia distinct subclasses of the disease-what does the placenta reveal? Hypertens Pregnancy 29, 457-467 (2010
32. Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M. & Nicolaides, K. H. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31, 66-74 (2011
33. Scazzocchio, E. et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol 208, 203.e1-e10 (2013
34. Parra-Cordero, M. et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet Gynecol 41, 538-544 (2013
35. Forest, J. C. et al.Candidate biochemical markers for screening of pre-eclampsia in early pregnancy. Clin Chem Lab Med 50, 973-984 (2012
36. Fu, G., Brkić, J., Hayder, H. & Peng, C. MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci 14, 5519-5544 (2013
37. Caradeux, J. et al. First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study. Prenat Diagn 33, 732-736 (2013
38. Grigorenko, E. V., Ortenberg, E., Hurley, J., Bond, A. & Munnelly, K. miRNA profiling on high-throughput OpenArrayTM system. Methods Mol Biol 676, 101-110 (2011
39. He, J. et al. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis. PLoS One 8, e56647 (2013
40. He, J. et al. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol Sci 134, 26-38 (2013
41. Prior, C. et al. Identification of tissuemicroRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma. PLoS One 9, e86263 (2014
42. Zhang, Y. et al.miR-126 andmiR-126 et al.repress recruitment ofmesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 15, 284-294 (2013
43. Chou, W. W. et al. Decreased microRNA-221 is associated with high levels of TNF-A in human adipose tissue-derived mesenchymal stem cells from obese woman. Cell Physiol Biochem 32, 127-137 (2013
44. Yamamoto, M. et al. Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics 13, 655 (2012
45. Xie, T. et al. MicroRNA-127 inhibits lung inflammation by targeting IgG Fcc receptor I. J Immunol 188, 2437-2444 (2012
46. Aguado-Fraile, E. et al. miR-127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 target. PLoS One 7, e44305 (2012
47. Li, Y. et al. MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. J Exp Clin Cancer Res 32, 33 (2013
48. Yang, Z., Zhang, Y. & Wang, L. A feedback inhibition between miRNA-127 and TGFb/c-Jun cascade in HCC cell migration via MMP13. PLoS One 8, e65256 (2013
49. Wu, D. et al. MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. Mol Med Rep 8, 626-630 (2013
50. Albinsson, S. et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 6, e18869 (2011
51. Vitoratos, N.,Hassiakos, D.&Iavazzo, C. Molecular mechanisms of preeclampsia. J Pregnancy 2012, 298343 (2012
52. Varkonyi-Gasic, E. &Hellens, R. P. Quantitative stem-loop RT-PCR for detection of microRNAs. Methods Mol Biol 744, 145-157 (2011
53. Chen, Y., Gelfond, J. A., McManus, L. M. & Shireman, P. K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10, 407 (2009
54. Sato, F., Tsuchiya, S., Terasawa, K. & Tsujimoto, G. Intra-platform repeatability and inter-platform comparability of microRNAmicroarray technology. PLoS One 4, e5540 (2009
55. Yauk, C. L., Rowan-Carroll, A., Stead, J. D. H. & Williams, A. Cross-platform analysis of global microRNA expression technologies. BMC Genomics 11, 330 (2010
56. Brown, M. A., Lindheimer, M. D., de Swiet, M., Van Assche, A. &Moutquin, J. M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20, IX-XIV (2001
57. Robinson, H. P. & Fleming, J. E. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 82, 702-710 (1975
58. Figueras, F. et al. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 136, 20-24 (2008
59. Hurley, J., Roberts, D., Bond, A., Keys, D. & Chen, C. Stem-loop RT-qPCR for microRNA expression profiling. Methods Mol Biol 822, 33-52 (2012).